Sanofi (NASDAQ: SNY) suffers from exceptional negative changes in investment behavior: its longer term price trend turned down, and negative upside/downside volume developed.
Sanofi (NASDAQ: SNY) suffers from notable negative changes in fundamentals: the stock’s power rating fell below 50, and significant quarterly sales deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Sanofi has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Sanofi has a good Appreciation Score of 74 but a neutral Power Rating of 44, leading to the High Neutral Value Trend Rating.
Recent Price Action
Sanofi (NASDAQ: SNY) stock closed at $45.89 on 12/16/24 after a modest decline of -1.9%. Moreover, unusually high trading volume at 185% of normal accompanied the decline. The stock has declined -5.3% during the last week but has been strong relative to the market over the last nine months.
Be the first to comment